USL 25 (Topiragen 25 mg)
Generic Name: topiramate
Pill imprint USL 25 has been identified as Topiragen 25 mg.
Topiragen is used in the treatment of obesity; migraine prevention; fibromyalgia; vulvodynia; smoking cessation (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiragen 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- USL 25
- 25 mg
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Upsher-Smith Laboratories, Inc
- National Drug Code (NDC):
More about Topiragen (topiramate)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- 1 Review – Add your own review/rating
- Drug class: carbonic anhydrase inhibitor anticonvulsants
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.